Localization-based ultrasound super-resolution imaging using microbubble contrast agents and phase-change nanodroplets has been developed to visualize microvascular structures beyond the diffraction limit. However, the long data acquisition time makes the clinical translation more challenging. In this study, fast acoustic wave sparsely activated localization microscopy (fast-AWSALM) was developed to achieve superresolved frames with subsecond temporal resolution, by using low-boiling-point octafluoropropane nanodroplets and high frame rate plane waves for activation, destruction, as well as imaging. Fast-AWSALM was demonstrated on an in vitro microvascular phantom to super-resolve structures that could not be resolved by conventional B-mode imaging. The effects of the temperature and mechanical index on fast-AWSALM were investigated. The experimental results show that subwavelength microstructures as small as 190 µm were resolvable in 200 ms with plane-wave transmission at a center frequency of 3.5 MHz and a pulse repetition frequency of 5000 Hz. This is about a 3.5-fold reduction in point spread function full-width-half-maximum compared to that measured in the conventional B-mode, and two orders of magnitude faster than the recently reported AWSALM under a nonflow/very slow flow situations and other localization-based methods. Just as in AWSALM, fast-AWSALM does not require flow, as is required by current microbubblebased ultrasound super-resolution techniques. In conclusion, this study shows the promise of fast-AWSALM, a super-resolution ultrasound technique using nanodroplets, which can generate super-resolution images in milliseconds and does not require flow.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.